Delivery Order SPE2DE24D0013-SPE2D625F0CBC
- Not listed
- The U.S. Defense Department's Medical Supply Chain awarded a $1,925 firm fixed-price delivery order to Cepheid Inc. on August 13, 2025, with an ultimate completion date of August 20, 2025. The contract, identified as XPRSARS-COV2-10, represents a delivery order under a larger vehicle and carries no set-aside designation. Work will be performed at Cepheid's headquarters in Sunnyvale, California. Cepheid, a leading manufacturer of molecular diagnostic solutions, specializes in advanced...
- The Defense Department's Medical Supply Chain agency awarded a $1,540 firm fixed-price delivery order to Cepheid Inc., a molecular diagnostic solutions manufacturer based in Sunnyvale, California, on September 3, 2025, with an ultimate completion date of September 10, 2025. The contract, designated XPRSARS-COV2-10, carries no set-aside designation and represents a delivery order likely issued under one of Cepheid's existing Indefinite Delivery Vehicle contracts with the Department of Veterans...
- The U.S. Defense Department's Medical Supply Chain division awarded a $3,850 firm fixed-price delivery order to Cepheid Inc. on August 25, 2025, with an ultimate completion date of September 2, 2025. The contract, numbered 4569219084 and designated XPRSARS-COV2-10, carries no set-aside designation and will be performed at Cepheid's headquarters in Sunnyvale, California. This delivery order represents a discrete procurement under one of Cepheid's existing federal contract vehicles, continuing the...
- The U.S. Defense Department's Medical Supply Chain has awarded a $5,082 firm fixed-price delivery order to Cepheid Inc., a Sunnyvale, California-based molecular diagnostics manufacturer, for SARS-CoV-2 testing supplies. The contract, awarded on August 4, 2025, with an ultimate completion date of August 18, 2025, carries no set-aside designation and will be performed at Cepheid's primary facility in Sunnyvale. This delivery order falls under Cepheid's existing indefinite delivery vehicle...
- The U.S. Defense Department's Medical Supply Chain awarded a $5,775 firm fixed-price delivery order to Cepheid Inc. on August 5, 2025, with an ultimate completion date of August 12, 2025. This delivery order, designated XPRSARS-COV2-10, carries no set-aside designation and represents a procurement of molecular diagnostic solutions from the Sunnyvale, California-based manufacturer. Cepheid specializes in advanced diagnostic systems and test kits for infectious diseases, including COVID-19,...
- The U.S. Defense Department's Medical Supply Chain division awarded a $29,520 firm fixed-price delivery order to Cepheid Inc. on August 28, 2025, with an ultimate completion date of September 5, 2025. The contract, which carries no set-aside designation, is for molecular diagnostic solutions to be performed at Cepheid's facility in Sunnyvale, California. Cepheid, a for-profit manufacturer of advanced diagnostic systems and test kits, specializes in detecting infectious diseases and clinical...
- Cepheid, a leading manufacturer of molecular diagnostic solutions based in Sunnyvale, California, was awarded a delivery order valued at $2,471.70 by the Medical Supply Chain division of the Defense Department on August 7, 2025. This firm fixed-price delivery order, which carries no set-aside designation, is scheduled for ultimate completion by August 21, 2025, and will be performed at Cepheid's Sunnyvale facility. The contract award references XPRSARS-COV2-10, indicating the delivery order...
- The U.S. Defense Department's Medical Supply Chain organization awarded a $2,024 firm fixed-price delivery order to Cepheid Inc. on August 7, 2025, with an ultimate completion date of August 14, 2025. The delivery order, designated XPRSTREPA-10, was issued without a set-aside designation to the Sunnyvale, California-based molecular diagnostics manufacturer. This delivery order represents a continuation of Cepheid's longstanding federal contract relationship, drawing from the company's existing...
- Cepheid Inc., a Sunnyvale, California-based manufacturer of molecular diagnostic solutions, received a $6,800 firm fixed-price delivery order (XPRS4PLEX-10) from the Defense Department's Medical Supply Chain on August 22, 2025, with an ultimate completion date of August 29, 2025. This delivery order carries no set-aside designation and represents a continuation of Cepheid's ongoing provision of molecular diagnostic technologies and test kits to federal defense and healthcare systems. This...
- The U.S. Defense Department's Medical Supply Chain agency awarded a $1,800 firm fixed-price delivery order to Cepheid Inc., a leading molecular diagnostics manufacturer headquartered in Sunnyvale, California. This delivery order, issued on August 25, 2025, with an ultimate completion date of September 2, 2025, carries no set-aside designation and represents a continuation of the agency's procurement of advanced diagnostic solutions. The work will be performed at Cepheid's Sunnyvale facility....
- SPE2DE24D0013Indefinite Delivery Contract
- SPE2DE24D0013-SPE2D625F0CBCDelivery Order
The Department of Defense's Medical Supply Chain awarded a $1,699.50 firm fixed-price delivery order to Cepheid Inc., a Sunnyvale, California-based manufacturer of molecular diagnostic solutions, on August 4, 2025, with an ultimate completion date of August 11, 2025. This delivery order, designated XPRSARS-COV2-DOD, carries no set-aside designation and represents a continuation of Cepheid's established role as a federal supplier of diagnostic equipment and testing solutions. The contract references the company's expertise in providing molecular diagnostic systems and reagents, with particular relevance to COVID-19 detection capabilities. Cepheid maintains substantial existing federal relationships through two significant Indefinite Delivery Vehicle contracts with the Veterans Administration, including a $32.8 million single-award IDV with VA's Veterans Integrated Service Network 6 running through September 30, 2030, and a $2.5 million IDV with Veterans Integrated Service Network 21 focused on PCR testing for laboratory microbiology. The current delivery order likely leverages one of these existing vehicles or represents a standalone procurement to address specific COVID-19 diagnostic requirements within the Defense Logistics Agency's medical supply chain. Cepheid's federal contract portfolio demonstrates consistent performance in supplying molecular diagnostic systems and assays for infectious disease detection across multiple federal agencies and healthcare networks.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.7k | 8/4/25 |